These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5158422)

  • 41. [Low-molecular dextran (40,000) in the treatment of scleroderma].
    Szczepański A; Zielińska Z; Polkowska M; Lorenc B
    Przegl Dermatol; 1975; 62(1):79-82. PubMed ID: 1111035
    [No Abstract]   [Full Text] [Related]  

  • 42. [Initial results of high-dosage hyaluromidase long-term therapy ("Hylase" Dessau) in dermatology].
    Wozniak KD; Braun W
    Dtsch Gesundheitsw; 1972 Jun; 27(22):1046-8. PubMed ID: 4557763
    [No Abstract]   [Full Text] [Related]  

  • 43. [Gestagen treatment of sclerodermia].
    Kortng GW; Holzmann H
    Asthet Med (Berl); 1967 Oct; 16(10):291-4. PubMed ID: 5301653
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of scleroderma].
    Wüthrich B
    Schweiz Rundsch Med Prax; 1973 Sep; 62(38):1149-55. PubMed ID: 4148265
    [No Abstract]   [Full Text] [Related]  

  • 45. [The sclerodermas].
    Huriez C
    Lille Med; 1971 Dec; 16(10):1358-69. PubMed ID: 5160880
    [No Abstract]   [Full Text] [Related]  

  • 46. [Follow-up examinations of patients treated with EDTA for scleroderma].
    Langhof H
    Dermatol Wochenschr; 1965 Jul; 151(30):862-4. PubMed ID: 4954170
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment with hyaluronidase in dermatology].
    Wozniak KD; Braun W
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1109-10. PubMed ID: 1226845
    [No Abstract]   [Full Text] [Related]  

  • 48. [The effect of procaine, griseofulvin and chloroquine on skin perfusion in progressive scleroderma].
    Wiskemann A; Korff F
    Dermatol Wochenschr; 1967 Sep; 153(37):1033-7. PubMed ID: 5589729
    [No Abstract]   [Full Text] [Related]  

  • 49. Scleroderma--developing measures of response.
    Furst DE; Khanna D; Mattucci-Cerinic M; Silman AJ; Merkel PA; Foeldvari I;
    J Rheumatol; 2005 Dec; 32(12):2477-80. PubMed ID: 16331791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children.
    Weibel L; Sampaio MC; Visentin MT; Howell KJ; Woo P; Harper JI
    Br J Dermatol; 2006 Nov; 155(5):1013-20. PubMed ID: 17034534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral calcitriol as a new therapeutic agent in localized and systemic scleroderma.
    Humbert P; Aubin F; Dupond JL; Delaporte E
    Arch Dermatol; 1995 Jul; 131(7):850-1. PubMed ID: 7611809
    [No Abstract]   [Full Text] [Related]  

  • 52. [A contribution to the effects of synthetic progesterone on systemic scleroderma (author's transl)].
    Ishikawa H; Tamura T; Horiuchi R; Tuihiji T; Ishii Y
    Nihon Hifuka Gakkai Zasshi; 1975 Apr; 85(5):299-301. PubMed ID: 125813
    [No Abstract]   [Full Text] [Related]  

  • 53. [Prognosis and treatment of scleroderma].
    Crickx B; Belaich S
    Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Madecassol treatment of systemic and localized scleroderma].
    Guseva NG; Starovoĭtova MN; Mach ES
    Ter Arkh; 1998; 70(5):58-61. PubMed ID: 9644746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Iloprost for scleroderma.
    Constans T; Diot E; Lasfargues G
    Ann Intern Med; 1991 Apr; 114(7):606. PubMed ID: 1705762
    [No Abstract]   [Full Text] [Related]  

  • 56. Systemic sclerosis and localized scleroderma in childhood.
    Zulian F
    Rheum Dis Clin North Am; 2008 Feb; 34(1):239-55; ix. PubMed ID: 18329543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Gestagens in the treatment of scleroderma].
    Szczepański A
    Przegl Dermatol; 1973; 60(4):521-3. PubMed ID: 4755917
    [No Abstract]   [Full Text] [Related]  

  • 58. Iloprost as cyclic five-day infusions in the treatment of scleroderma. An open pilot study in 20 patients treated for one year.
    Biasi D; Carletto A; Caramaschi P; Zeminian S; Pacor ML; Corrocher R; Bambara LM
    Rev Rhum Engl Ed; 1998 Dec; 65(12):745-50. PubMed ID: 9923042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salazopyrin in the treatment of scleroderma.
    Stáva Z; Kobíková M
    Br J Dermatol; 1977 May; 96(5):541-4. PubMed ID: 17429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Other rheumatic diseases in adolescence. Dermatomyositis, scleroderma, overlap syndromes, systemic vasculitis, and panniculitis.
    Hom C; Ilowite NT
    Adolesc Med; 1998 Feb; 9(1):69-83, vi. PubMed ID: 10961253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.